The company will conduct a six-week premarketing trial at the Schneider Children's Hospital.
D Medical Industries Ltd. (TASE:DMDC) portfolio company NiliMedix Ltd. has obtained Ministry of Health approval for the company's insulin pump and infusion sets. The approval is for one year.
The company will conduct a six-week premarketing trial at the Schneider Children's Hospital in Petah Tikva. The study aimed at testing safety and diabetics' satisfaction with the device. Commercial marketing of the pump will begin after conclusion of the trial.
The insulin pump already has US Food and Drug Administration (FDA) approval and EU CE Mark certification.
Published by Globes [online], Israel business news - www.globes-online.com - on November 16, 2008
© Copyright of Globes Publisher Itonut (1983) Ltd. 2008